Concord Drugs Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	787.37	452.45	449.25	520.81	589.57
Other Revenue	0.35	0	-	-	0.86
Revenue	787.71	452.45	449.25	520.81	590.43
Revenue Growth (YoY)	74.10%	0.71%	-13.74%	-11.79%	14.77%
Cost of Revenue	676.46	356.47	337.33	415.96	425.7
Gross Profit	111.25	95.98	111.92	104.85	164.73
Selling, General & Admin	49.71	46.35	60.76	49.19	48.91
Other Operating Expenses	16.01	8.29	10.73	9.94	7.55
Operating Expenses	79.39	68.94	87.04	75.38	125.59
Operating Income	31.87	27.04	24.87	29.46	39.14
Interest Expense	-17.14	-19.19	-18.17	-16.34	-15.79
Interest & Investment Income	-	0.14	0.09	0.06	0.12
Other Non Operating Income (Expenses)	-	-1.08	-0.5	-0.7	-0.99
EBT Excluding Unusual Items	14.73	6.91	6.29	12.49	22.48
Pretax Income	14.73	6.91	6.29	12.49	22.48
Income Tax Expense	4.18	3.55	1.57	2.63	6.54
Net Income	10.55	3.36	4.72	9.86	15.94
Net Income to Common	10.55	3.36	4.72	9.86	15.94
Net Income Growth	213.80%	-28.82%	-52.08%	-38.19%	-51.42%
Shares Outstanding (Basic)	11	10	10	9	9
Shares Outstanding (Diluted)	11	10	10	9	9
Shares Change (YoY)	11.05%	-	7.35%	6.53%	-
EPS (Basic)	0.95	0.34	0.47	1.06	1.82
EPS (Diluted)	0.95	0.34	0.47	1.06	1.82
EPS Growth	182.57%	-28.47%	-55.57%	-41.87%	-51.47%
Free Cash Flow	-79.33	13.89	-2.26	8.06	-16.82
Free Cash Flow Per Share	-7.14	1.39	-0.23	0.87	-1.92
Gross Margin	14.12%	21.21%	24.91%	20.13%	27.90%
Operating Margin	4.05%	5.98%	5.54%	5.66%	6.63%
Profit Margin	1.34%	0.74%	1.05%	1.89%	2.70%
Free Cash Flow Margin	-10.07%	3.07%	-0.50%	1.55%	-2.85%
EBITDA	45.54	41.34	40.43	45.72	56.79
EBITDA Margin	5.78%	9.14%	9.00%	8.78%	9.62%
D&A For EBITDA	13.67	14.31	15.55	16.26	17.65
EBIT	31.87	27.04	24.87	29.46	39.14
EBIT Margin	4.05%	5.98%	5.54%	5.66%	6.63%
Effective Tax Rate	28.39%	51.37%	24.89%	21.09%	29.08%
Revenue as Reported	787.71	452.59	449.34	520.89	590.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.